STAT+: Pharmalittle: Three big drugmakers spent less on lobbying after leaving PhRMA; EMA reviews CRO over data concerns

Three companies that left the Pharmaceutical Research & Manufacturers of America spent less on lobbying afterward.
Click here to view original post